Mira Pharmaceuticals (MIRA) Invested Capital (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Invested Capital of $10.4 million for Q4 2025, up 38.67% sequentially from $7.5 million in Q3 2025, and up 372.78% YoY from $2.2 million in Q4 2024.
Mira Pharmaceuticals (MIRA) Invested Capital (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Invested Capital data on file, last reported at $10.4 million in Q4 2025.
- Quarterly Invested Capital rose 372.78% year-over-year to $10.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.4 million (up 372.78% YoY) and the FY2025 annual result came in at $10.4 million, up 372.78% from the prior year.
- Invested Capital advanced to $10.4 million in Q4 2025 per MIRA's latest filing, from $7.5 million in the prior quarter.
- The five-year high for Invested Capital was $10.4 million in Q4 2025, with the low at -$1.8 million in Q1 2023.
- Average Invested Capital over 4 years is $3.2 million, with a median of $2.6 million recorded in 2023.
- Year-over-year, Invested Capital soared 2432.48% in 2023 and sank 74.32% in 2025.
- Mira Pharmaceuticals' Invested Capital stood at -$463170.0 in 2022, then soared by 1044.44% to $4.4 million in 2023, then plunged by 49.71% to $2.2 million in 2024, then jumped by 372.78% to $10.4 million in 2025.
- Business Quant data shows MIRA's Invested Capital at $10.4 million in Q4 2025, $7.5 million in Q3 2025, and $569859.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 72.79 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 98.65 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -6.66 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 48.32 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 66.51 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 45.69 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 90.96 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -19.00 Mn |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 569,859.00 |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 2.22 Mn |
| Mar 31, 2024 | 3.16 Mn |
| Dec 31, 2023 | 4.37 Mn |
| Sep 30, 2023 | 8.12 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | -1.79 Mn |
| Dec 31, 2022 | -463,170.00 |
| Sep 30, 2022 | 320,449.00 |